Sku |
AAP43834 |
Old sku |
AAPP26614 |
Price |
$99.00 |
Name |
SLC6A1 Peptide - middle region (AAP43834) |
Purchase info |
To purchase this peptide:
- Copy peptide sku
- Click on this link
- Paste into field "Peptide Sku"
|
Size |
100 ug |
Gene |
SLC6A1 |
Alias symbols |
GABATHG, GABATR, GAT1 |
Gene id |
6529 |
Description of target |
SLC6A1 terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine. |
Swissprot id |
P30531 |
Protein accession num |
NP_003033 |
Nucleotide accession num |
NM_003042 |
Protein size |
599 amino acids |
Molecular weight |
67kDa |
Application |
IHC, WB |
Partner proteins |
STX1A,STX1A |
Quality control |
The peptide is characterized by mass spectroscopy |
Key reference |
Gotlib,I.H., (2008) Biol. Psychiatry 63 (9), 847-851 |
Description |
This is a synthetic peptide designed for use in combination with anti-SLC6A1 antibody (Catalog #: ARP43834_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details. |
Product format |
Lyophilized powder |
Reconstitution and storage |
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles. |
Lead time |
Domestic: within 24 hours delivery International: 3-5 business days |
Protocol |
|
Tips |
See our General FAQ page. |
Availability |
In Stock |